CLASS II ONGOING Drug recall · Reported 28 May 2025 · FDA Enforcement Report

Phentermine Hydrochloride Capsules, USP 30mg recalled by KVK Tech

KVK Tech is recalling Phentermine Hydrochloride Capsules, USP 30mg, distributed nationwide in the US. The recall was initiated on 9 May 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot#: 18350A, 18351A, Exp 6/30/2027
NDC10702-026, 10702-027, 10702-028
UPC0310702027107, 0310702028104, 0310702026100
Quantity recalled9680 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0446-2025
FDA event ID
96847
Recalling firm
KVK Tech, Newtown, PA
Manufacturer
KVK-Tech, Inc.
Classification
Class II
Status
Ongoing
Recall initiated
9 May 2025
FDA classified
21 May 2025
Reported
28 May 2025
Type
Voluntary: Firm initiated
Customers notified by
E-Mail

Timeline

9 May 2025Recall initiated by company
21 May 2025Classified by FDA+12 days
28 May 2025Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

cGMP deviations

Product as listed by the FDA

Phentermine Hydrochloride Capsules, USP 30mg, 100-count bottle, Rx Only, Mfd. By: KVK-Tech, Inc., Newtown, PA, 18940, Made in USA, NDC 10702-028-01.

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Why was it recalled?

cGMP deviations

Which lots are affected?

Lot#: 18350A, 18351A, Exp 6/30/2027

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 96847

This product is part of a recall event; the main page for the event is Indomethacin Extended-Release Capsules USP, 75 mg recalled by KVK Tech.

ReportedClassRecallCompanyReasonWhere
CLASS IIIndomethacin Extended-Release Capsules USP, 75 mg recalled by KVK TechIndomethacinKVK TechManufacturing (CGMP) DeviationsNationwide

More recalls from KVK Tech

All 15
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIIndomethacin Extended-Release Capsules USP, 75 mg recalled by KVK TechIndomethacinKVK TechManufacturing (CGMP) DeviationsNationwide
DrugCLASS IBetaxolol Tablets, USP 10 mg recalled by KVK-TechBetaxolol HydrochlorideKvk-TechOtherNationwide
DrugCLASS IAtovaquone Oral Suspension, USP, 750 mg recalled by KVK-TechAtovaquone Oral SuspensionKvk-TechTemperature AbuseNationwide
DrugCLASS IIIHydrocodone Bitartrate and Homatropine Methlybromide recalledHydrocodone Bitartrate And Homatropine MethylbromideKvk-TechPotency & AssayNationwide
DrugCLASS IIIBenzhydrocodone and Acetaminophen Tablets, CII, 6.12mg/ 325mg recalledKvk-TechPotency & AssayNationwide

Other Phentermine recalls

All 8